Spirea Limited is a Cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. Spirea will use its innovative technology to enable a pipeline of superior and differentiated antibody drug conjugates for the treatment of a range of solid tumours.



Biotechnology

Research

Spirea

The Cambridge office focuses on strategic leadership and business development, leveraging historical innovation and advisory expertise.

Cambridge

Spirea's headquarters in Cambridge, MA, United States

People (4)

Jobs (0)

Other offices